Synthetic DNA-delivered antibodies protect against Ebola in preclinical studies

Scientists have successfully engineered novel DNA-encoded monoclonal antibodies (DMAbs) targeting Zaire Ebolavirus that were effective in preclinical models. Study results showed that DMAbs were expressed over a wide window of time and offered complete and long-term protection against lethal virus challenges. DMAbs may also provide a novel powerful platform for rapid screening of monoclonal antibodies enhancing preclinical development.

Source: Synthetic DNA-delivered antibodies protect against Ebola in preclinical studies

Posted in: AICHC News

Leave a Comment (0) ↓